Integra Lifesciences Holdings (IART) Cost of Revenue (2009 - 2026)
Integra Lifesciences Holdings (IART) posted Cost of Revenue of $199.0 million for Q2 2026, up 13.77% sequentially from $174.9 million in Q1 2026, and down 3.52% YoY from $206.3 million in Q2 2025.
Integra Lifesciences Holdings (IART) Cost of Revenue (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported Cost of Revenue for 18 years, with the latest figure at $199.0 million in Q2 2026.
- Quarterly Cost of Revenue fell 3.52% year-over-year to $199.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $783.1 million (up 1.88% YoY) and the FY2025 annual result came in at $803.6 million, up 10.32% from the prior year.
- Cost of Revenue improved to $199.0 million in Q2 2026 per IART's latest filing, from $174.9 million in the prior quarter.
- Over five years, Cost of Revenue peaked at $214.1 million in Q4 2025 and troughed at $142.6 million in Q1 2022.
- A 5-year average of $175.0 million and a median of $174.6 million in 2023 frame the typical range for Cost of Revenue.
- The sharpest annual moves came in 2023 and 2026: Cost of Revenue advanced 17.41% in 2023, then dropped 7.06% in 2026.
- Over 5 years, Cost of Revenue stood at $147.9 million in 2022, then rose by 15.28% to $170.5 million in 2023, then grew by 13.5% to $193.6 million in 2024, then increased by 10.58% to $214.1 million in 2025, then decreased by 7.03% to $199.0 million in 2026.
- According to Business Quant data, Cost of Revenue over the past three periods registered $199.0 million, $174.9 million, and $214.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 808.60 Mn |
| 10 | Integra Lifesciences Holdings | 1.32 Bn | 1.05 Bn | 219.74 Mn | 199.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 199.02 Mn |
| Jun 30, 2026 | 199.02 Mn |
| Mar 31, 2026 | 174.94 Mn |
| Mar 31, 2026 | 174.94 Mn |
| Dec 31, 2025 | 214.06 Mn |
| Dec 31, 2025 | 214.06 Mn |
| Sep 30, 2025 | 195.07 Mn |
| Sep 30, 2025 | 195.07 Mn |
| Jun 30, 2025 | 206.27 Mn |
| Jun 30, 2025 | 206.27 Mn |
| Mar 31, 2025 | 188.22 Mn |
| Mar 31, 2025 | 188.22 Mn |
| Dec 31, 2024 | 193.57 Mn |
| Dec 31, 2024 | 193.57 Mn |
| Sep 30, 2024 | 180.60 Mn |
| Sep 30, 2024 | 180.60 Mn |
| Jun 30, 2024 | 192.26 Mn |
| Jun 30, 2024 | 192.26 Mn |
| Mar 31, 2024 | 162.04 Mn |
| Mar 31, 2024 | 162.04 Mn |